populate inflamed or cancerous tissue and block immune cell effector functions. The lack of
mechanistic insight into MDSC suppressive activity and a marker for their identification has
hampered attempts to overcome T cell inhibition and unleash anti-cancer immunity. Here,
we report that human MDSCs were characterized by strongly reduced metabolism and
conferred this compromised metabolic state to CD8+ T cells, thereby paralyzing their effector …